Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Moody is a health-tracking application that connects users with customised health, food and fitness advice based on their moods, symptoms and cycles. It endeavours to become a sustainable force for good in women's health. The company argues that women control >80% of household health spend and are 80% more likely than men to use a digital health app. It aims to harness these trends and capitalise on the global remote health care market that is forecast to hit £40 billion by 2025. 'The Moody Month' app featured in publications like Vogue, Grazia and The Guardian. It has witnessed over 136,000 downloads since its Version 1 release in 2019. The app has compiled over 5 million moods to date. The company will use the investment to scale its business globally and reach 1 million subscribers within a four-year time frame.
days to go:
Expired
investment:
£142,026
Oneskee is the one-piece snow brand that aims to re-ignite a forgotten product category. Oneskee asserts that it successfully navigated its way through the COVID-19 pandemic recording £500,000 in online revenue with 25% online growth in the 2020-2021 financial year. It has sold 10,000 suits across 79 countries since its launch and aims to become a contender in the snow brand industry that is growing more than £1 billion each year. The company has partnered with Olympic athletes, GB Snowsport, Folie Douce, and Snowboxx and received media recognition from the likes of BBC, Vogue, InTheSnow, The Telegraph, The Independent, and Eurosport. Oneskee is also continuing its work on its patent-protected Acclimate technology and kids collection which it intends to launch in 2021. Oneskee will use the investment to accelerate the roll-out of its successful online blueprint to all ski countries and create a dedicated resource for B2B sales.
days to go:
Expired
investment:
£215,618
Hemspan states that it designs bio-based building systems and products for construction by combining modern methods, technology and hemp to produce net-zero carbon solutions. The company argues that every time an average house is built, the CO2 emitted by the manufacture, transport and assembly of the materials used is around 50 to 60 tonnes. Hemspan says that one hectare of UK-grown industrial hemp can absorb 11 tonnes of CO2 each year with regeneratively farmed hemp capable of sequestering a further 6 tonnes per hectare of CO2 into the soil each year. Hemspan intends to activate significant demand for hemp farming in the UK and develop processing technologies to reduce reliance on imports and enable large scale manufacturing of bio-based cladding and insulation products that spin out of R&D programmes. It asserts that the global industrial hemp market is expected to grow at 25% CAGR reaching US$ 27 billion by 2028. It aims to be a contender in this segment.
days to go:
Expired
investment:
£200,000
Alert Technology Limited is set to transform health and safety best practice for asbestos management by introducing ALERT - a new generation of real-time asbestos monitoring. With the large potential market, Alert will give market priority to the sectors who have demonstrated the greatest need. ALERT is the only solution to the global problem that impacts 30+ industry sectors. Till now, they have successfully launched the ALERT PRO 1000-the first model in the range and won an industry award in the asbestos category. With the investment, they will strengthen their team by recruiting a new Sales Director, Technical Sales Support, Technicians and Service Engineers to boost the in-house team, expand distribution, drive sales, scale-up assembly and service customers.
days to go:
Expired
investment:
£10,000
Gunna Drinks (GD) manufactures and sells craft soft drinks, consisting of natural juices with less than 5% sugar having zero artificial colours or flavours. The company asserts that it has outshone established competitors like Gingerella, Fentimans and FeverTree in taste tests. GD is stocked in major supermarkets and convenience stores across the UK such as Co-ops, Sainsbury’s, Amazon, Ocado, and JD Wetherspoon. The company won the prestigious 'Great Taste Award' in 2020 and witnessed more than doubled revenues in 2018-2020, with a 23% growth in 2020 despite COVID. The company will utilise the investment to boost consumer advertising to accelerate the growth of its online store, focus on trade investment to further increase the rate of sale, and concentrate on New Product Development (NPD).
days to go:
Expired
investment:
£696,261
Real Stars Are Rare has been created by singer/songwriter Paul Weller and retailer Phil Bickley. They have designed timeless and stylish pieces in top quality materials which can be bought online or in Phil's shop 'Tonic' on the Portobello Road.
days to go:
Expired
investment:
£232,550
